Sanodyne Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.38M
- Investors
-
2
Sanodyne Therapeutics General Information
Description
Developer of biotech-driven pain management treatments designed to support individuals affected by peripheral neuropathy and chronic pain. The company pioneers breakthrough therapies that address the root causes of nerve damage, enabling patients to enhance well-being and improve long-term quality of life.
Contact Information
Website
www.sanodyne.comCorporate Office
- 7 Floor, Nihonbashi Muromachi Mitsui Tower
- 3-2-1 Nihonbashi Muromachi Chuo
- Tokyo, 103-0022
- Japan
Corporate Office
- 7 Floor, Nihonbashi Muromachi Mitsui Tower
- 3-2-1 Nihonbashi Muromachi Chuo
- Tokyo, 103-0022
- Japan
Sanodyne Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 05-Jun-2025 | $1.38M | Completed | Clinical Trials - Phase 1 |
Sanodyne Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| S1 Shares |
Sanodyne Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JIC Venture Growth Investments | Venture Capital | Minority | ||
| Remiges Ventures | Venture Capital | Minority |
Sanodyne Therapeutics FAQs
-
When was Sanodyne Therapeutics founded?
Sanodyne Therapeutics was founded in 2025.
-
Where is Sanodyne Therapeutics headquartered?
Sanodyne Therapeutics is headquartered in Tokyo, Japan.
-
What industry is Sanodyne Therapeutics in?
Sanodyne Therapeutics’s primary industry is Drug Discovery.
-
Is Sanodyne Therapeutics a private or public company?
Sanodyne Therapeutics is a Private company.
-
What is the current valuation of Sanodyne Therapeutics?
The current valuation of Sanodyne Therapeutics is .
-
What is Sanodyne Therapeutics’s current revenue?
The current revenue for Sanodyne Therapeutics is .
-
How much funding has Sanodyne Therapeutics raised over time?
Sanodyne Therapeutics has raised $1.38M.
-
Who are Sanodyne Therapeutics’s investors?
JIC Venture Growth Investments and Remiges Ventures have invested in Sanodyne Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process